424 related articles for article (PubMed ID: 26230285)
1. Elevated growth differentiation factor 15 levels predict outcome in patients undergoing transcatheter aortic valve implantation.
Krau NC; Lünstedt NS; Freitag-Wolf S; Brehm D; Petzina R; Lutter G; Bramlage P; Dempfle A; Frey N; Frank D
Eur J Heart Fail; 2015 Sep; 17(9):945-55. PubMed ID: 26230285
[TBL] [Abstract][Full Text] [Related]
2. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
[TBL] [Abstract][Full Text] [Related]
3. Soluble ST2 for Risk Stratification and the Prediction of Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation.
Stundl A; Lünstedt NS; Courtz F; Freitag-Wolf S; Frey N; Holdenrieder S; Zur B; Grube E; Nickenig G; Werner N; Frank D; Sinning JM
Am J Cardiol; 2017 Sep; 120(6):986-993. PubMed ID: 28739033
[TBL] [Abstract][Full Text] [Related]
4. Preprocedural but not periprocedural high-sensitive Troponin T levels predict outcome in patients undergoing transcatheter aortic valve implantation.
Köhler WM; Freitag-Wolf S; Lambers M; Lutz M; Niemann PM; Petzina R; Lutter G; Bramlage P; Frey N; Frank D
Cardiovasc Ther; 2016 Dec; 34(6):385-396. PubMed ID: 27380819
[TBL] [Abstract][Full Text] [Related]
5. Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement.
Lindman BR; Breyley JG; Schilling JD; Vatterott AM; Zajarias A; Maniar HS; Damiano RJ; Moon MR; Lawton JS; Gage BF; Sintek MA; Aquino A; Holley CL; Patel NM; Lawler C; Lasala JM; Novak E
Heart; 2015 Sep; 101(17):1382-8. PubMed ID: 26037104
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
[TBL] [Abstract][Full Text] [Related]
7. Impact of N-terminal pro-B-type natriuretic peptide response on long-term prognosis after transcatheter aortic valve implantation for severe aortic stenosis and heart failure.
Kaneko H; Hoelschermann F; Tambor G; Okamoto M; Neuss M; Butter C
Heart Vessels; 2019 May; 34(5):777-783. PubMed ID: 30443765
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of N-terminal pro-B-type natriuretic peptide in patients with normal left ventricular ejection fraction undergoing transcatheter aortic valve implantation.
Seoudy H; Kuhn C; Frank J; Eden M; Rangrez AY; Lutter G; Frey N; Frank D
Int J Cardiol; 2020 Feb; 301():195-199. PubMed ID: 31757644
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification using growth differentiation factor 15 in patients undergoing transcatheter aortic valve implantation.
Sluka M; Hutyra M; Nykl R; Ostransky J; Furst T; Petrova P; Precek J; Hudec S; Taborsky M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Sep; 167(3):263-271. PubMed ID: 35416185
[TBL] [Abstract][Full Text] [Related]
10. Periprocedural Changes of NT-proBNP Are Associated With Survival After Transcatheter Aortic Valve Implantation.
Seoudy H; Frank J; Neu M; Güßefeld N; Klaus Y; Freitag-Wolf S; Lambers M; Lutter G; Dempfle A; Rangrez AY; Kuhn C; Frey N; Frank D
J Am Heart Assoc; 2019 Feb; 8(3):e010876. PubMed ID: 30686097
[TBL] [Abstract][Full Text] [Related]
11. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation.
Koskinas KC; O'Sullivan CJ; Heg D; Praz F; Stortecky S; Pilgrim T; Buellesfeld L; Jüni P; Windecker S; Wenaweser P
Am J Cardiol; 2015 Nov; 116(10):1560-5. PubMed ID: 26428025
[TBL] [Abstract][Full Text] [Related]
12. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 predicts short- and long-term outcome in patients undergoing transcatheter aortic valve implantation (TAVI).
Baldenhofer G; Zhang K; Spethmann S; Laule M; Eilers B; Leonhardt F; Sanad W; Dreger H; Sander M; Grubitzsch H; Baumann G; Stangl K; Stangl V; Knebel F
Int J Cardiol; 2014 Dec; 177(3):912-7. PubMed ID: 25456698
[TBL] [Abstract][Full Text] [Related]
14. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
[TBL] [Abstract][Full Text] [Related]
15. Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in Japan.
Mizutani K; Hara M; Nakao M; Okai T; Kajio K; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
BMJ Open; 2018 Aug; 8(8):e021468. PubMed ID: 30121598
[TBL] [Abstract][Full Text] [Related]
16. ST2 predicts survival in patients undergoing transcatheter aortic valve implantation.
Schmid J; Stojakovic T; Zweiker D; Scharnagl H; Maderthaner RD; Scherr D; Maier R; Schmidt A; März W; Binder JS; Rainer PP
Int J Cardiol; 2017 Oct; 244():87-92. PubMed ID: 28651919
[TBL] [Abstract][Full Text] [Related]
17. Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.
Sinning JM; Wollert KC; Sedaghat A; Widera C; Radermacher MC; Descoups C; Hammerstingl C; Weber M; Stundl A; Ghanem A; Widder J; Vasa-Nicotera M; Mellert F; Schiller W; Bauersachs J; Zur B; Holdenrieder S; Welz A; Grube E; Pencina MJ; Nickenig G; Werner N; Kempf T
Am Heart J; 2015 Oct; 170(4):821-9. PubMed ID: 26386807
[TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide is a strong independent predictor of long-term outcome after transcatheter aortic valve implantation.
Gotzmann M; Czauderna A; Aweimer A; Hehnen T; Bösche L; Lind A; Kloppe A; Mügge A; Ewers A
J Heart Valve Dis; 2014 Sep; 23(5):537-44. PubMed ID: 25799701
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of chronic kidney disease after transcatheter aortic valve implantation.
Yamamoto M; Hayashida K; Mouillet G; Hovasse T; Chevalier B; Oguri A; Watanabe Y; Dubois-Randé JL; Morice MC; Lefèvre T; Teiger E
J Am Coll Cardiol; 2013 Sep; 62(10):869-77. PubMed ID: 23707321
[TBL] [Abstract][Full Text] [Related]
20. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry.
Mizutani K; Hara M; Iwata S; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
